This Article Free upon publication Full Text Full Text (PDF) Data Supplement All Versions of this Article: 118/7/722    most recent CIRCULATIONAHA.107.736801v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hong, K.-H. Articles by Oh, S. P. Search for Related Content PubMed PubMed Citation Articles by Hong, K.-H. Articles by Oh, S. P. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Pulmonary Hypertension Related Collections Clinical genetics Animal models of human disease Other hypertension Growth factors/cytokines Smooth muscle proliferation and differentiation Pulmonary circulation and disease Endothelium/vascular type/nitric oxide Other Vascular biology Related Article

(Circulation. 2008;118:722-730.)
© 2008 American Heart Association, Inc.

Molecular Cardiology

Genetic Ablation of the Bmpr2 Gene in Pulmonary Endothelium Is Sufficient to Predispose to Pulmonary Arterial Hypertension

Kwon-Ho Hong, PhD; Young Jae Lee, PhD; Eunji Lee, MS; Sung Ok Park, PhD; Chul Han, MS; Hideyuki Beppu, MD, PhD; En Li, PhD; Mohan K. Raizada, PhD; Kenneth D. Bloch, MD; S. Paul Oh, PhD

From the Department of Physiology and Functional Genomics, Shands Cancer Center, University of Florida College of Medicine, Gainesville (K.-H.H., Y.J.L., E.L., S.O.P., C.H., M.K.R., S.P.O.); Lee Gil Ya Cancer and Diabetes Institute, Gachon University of Medicine and Science, Incheon, Republic of Korea (Y.J.L., S.P.O.); Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown (H.B., E.L., K.D.B.); and Anesthesia Center for Critical Care Research, Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston (H.B., K.D.B.).

Correspondence to S. Paul Oh, PhD, Department of Physiology and Functional Genomics, University of Florida, 1376 Mowry Rd, Room 456, Gainesville, FL 32610. E-mail ohp{at}phys.med.ufl.edu

Received October 16, 2007; accepted June 5, 2008.

Background— Pulmonary arterial hypertension (PAH) is a rare but fatal lung disease of diverse origins. PAH is now further subclassified as idiopathic PAH, familial PAH, and associated PAH varieties. Heterozygous mutations in BMPR2 can be detected in 50% to 70% of patients with familial PAH and 10% to 40% of patients with idiopathic PAH. Although endothelial cells have been suspected as the cellular origin of PAH pathogenesis, no direct in vivo evidence has been clearly presented. The present study was designed to investigate whether endothelial Bmpr2 deletion can predispose to PAH.

Methods and Results— The Bmpr2 gene was deleted in pulmonary endothelial cells using Bmpr2 conditional knockout mice and a novel endothelial Cre transgenic mouse line. Wide ranges of right ventricular systolic pressure were observed in mice with heterozygous (21.7 to 44.1 mm Hg; median, 23.7 mm Hg) and homozygous (20.7 to 56.3 mm Hg; median, 27 mm Hg) conditional deletion of Bmpr2 in pulmonary endothelial cells compared with control mice (19.9 to 26.7 mm Hg; median, 23 mm Hg) at 2 to 7 months of age. A subset of mice with right ventricular systolic pressure >30 mm Hg exhibited right ventricular hypertrophy and an increase in the number and wall thickness of muscularized distal pulmonary arteries. In the lungs of these mice with high right ventricular systolic pressure, the expression of proteins involved in the pathogenesis of PAH such as serotonin transporter and tenascin-C was elevated in distal arteries and had a high incidence of perivascular leukocyte infiltration and in situ thrombosis.

Conclusions— Conditional heterozygous or homozygous Bmpr2 deletion in pulmonary endothelial cells predisposes mice to develop PAH.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 118: 697-698. [Extract] [Full Text]

This article has been cited by other articles:

				K. R. Stenmark, B. Meyrick, N. Galie, W. J. Mooi, and I. F. McMurtry Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1013 - L1032. [Abstract] [Full Text] [PDF]

				C. Guignabert, C. M. Alvira, T.-P. Alastalo, H. Sawada, G. Hansmann, M. Zhao, L. Wang, N. El-Bizri, and M. Rabinovitch Tie2-mediated loss of peroxisome proliferator-activated receptor-{gamma} in mice causes PDGF receptor-{beta}-dependent pulmonary arterial muscularization Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1082 - L1090. [Abstract] [Full Text] [PDF]

				N. W. Morrell, S. Adnot, S. L. Archer, J. Dupuis, P. Lloyd Jones, M. R. MacLean, I. F. McMurtry, K. R. Stenmark, P. A. Thistlethwaite, N. Weissmann, et al. Cellular and molecular basis of pulmonary arterial hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S20 - S31. [Abstract] [Full Text] [PDF]